Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Innovent Biologics' mazdutide shows significant weight loss in Chinese adults, set to launch in China this year.
Innovent Biologics' Phase 3 study on mazdutide, a new obesity treatment, showed significant weight loss in Chinese adults with overweight or obesity, published in The New England Journal of Medicine.
The drug, which reduces body weight more effectively than a placebo, is set to launch in China this year for weight management and glycemic control.
Experts highlight the need for drug therapies to be combined with public health policies to address obesity effectively.
5 Articles
El mazdutide de Innovent Biologics muestra una importante pérdida de peso en adultos chinos, que se lanzará en China este año.